These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 17766714

  • 1. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S, Richardt A, Remer T, Wudy SA, Tomlinson JW, Hughes B, Grüters A, Stewart PM, Strasburger CJ, Quinkler M.
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue-specific dysregulation of cortisol metabolism in human obesity.
    Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM, Seckl JR.
    Front Horm Res; 2008 Mar; 36():146-164. PubMed ID: 18230901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X, Chen F, Zhu C, Lu Y.
    J Pharm Biomed Anal; 2015 Mar 25; 107():450-5. PubMed ID: 25668797
    [Abstract] [Full Text] [Related]

  • 13. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
    Stimson RH, Andrew R, McAvoy NC, Tripathi D, Hayes PC, Walker BR.
    Diabetes; 2011 Mar 25; 60(3):720-5. PubMed ID: 21266326
    [Abstract] [Full Text] [Related]

  • 14. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB.
    Int J Obes (Lond); 2009 Nov 25; 33(11):1249-56. PubMed ID: 19704410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct 25; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM.
    J Clin Endocrinol Metab; 2002 Dec 25; 87(12):5630-5. PubMed ID: 12466364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.